Circulating FGF21 Concentration, Fasting Plasma Glucose and the Risk of Type 2 Diabetes: Results from the PREVEND study.
Adrian PostWendy A DamSara SokootiDion GroothofJolein GloerichAlain J van GoolDaan KremerRon T GansevoortJacob van den BornIdo P KemaCasper F M FranssenRobin P F DullaartStephan J L BakkerPublished in: The Journal of clinical endocrinology and metabolism (2022)
Higher circulating FGF21 concentrations are independently associated with an increased risk of incident T2D in participants with a low fasting plasma glucose, making circulating FGF21 concentration a potential early biomarker for type 2 diabetes.